- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03372928
Essential Amino Acids and Protein Kinetics During Caloric Deprivation
October 28, 2020 updated by: United States Army Research Institute of Environmental Medicine
The Effects of Varying Essential Amino Acid Intakes on Resting and Post-exercise Skeletal Muscle and Whole-body Protein Kinetics During Negative Energy Balance
The amount of essential amino acids (EAA) necessary to maximally stimulate muscle protein synthesis and optimize whole-body net protein balance during caloric deprivation has not been determined.
This study will address that gap in knowledge by examining the resting and post-exercise muscle and whole-body protein kinetic responses to ingesting varying amounts of EAA after a 5 day period of negative energy balance.
This study will provide the initial evidence to support the development of a recovery-based food product for military combat rations.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Short-term negative energy balance downregulates muscle protein synthesis and upregulates whole-body proteolysis and amino acid (AA) oxidation, thereby increasing nitrogen excretion and exacerbating whole-body and skeletal muscle protein loss.
Consumption of quality proteins high in essential amino acid (EAA) content may attenuate protein loss during energy deficit by restoring whole-body and skeletal muscle anabolic potential to that observed in a eucaloric state.
During energy balance, muscle protein synthesis appears to be maximally stimulated after consuming 15 g of EAA at rest and after conventional resistance-type exercise.
In response to a short-term energy deficit that downregulated basal muscle protein synthesis by as much as 27%, consuming 15 g (~7.5 g EAA) and 30 g (~15 g EAA) of whey protein after a bout of resistance exercise restored muscle protein synthesis rates to resting, fasted rates observed in the eucaloric state in a dose dependent manner.
The effect of EAA intakes above 15 g on resting and post-exercise muscle protein synthesis and the whole-body protein anabolic response during acute energy deficit has not been determined.
This study will assess resting and post-resistance exercise whole-body and skeletal muscle protein synthesis responses to across a spectrum of EAA intakes following a well-controlled, short-term (5-d) energy deficit (30% energy deficit).
Using a randomized, double-blind, cross-over design, 20 resistance trained (≥ 2 d/wk for the past 6 mo) adults will undergo two, non-consecutive 5-d energy deficit periods, separated by a 14-d washout period.
Resting and post-resistance exercise (single leg exercise model) whole-body protein turnover and skeletal muscle protein synthesis responses to two different doses of EAA (standard, 0.10 g/kg vs high, 0.30 g/kg) will be determined the morning after completing the 5-d energy deficit.
This design will test the hypothesis that higher absolute doses of EAA are required to maintain resting and post-exercise anabolic responses during energy deficit.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- US Army Research Institute of Environmental Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 33 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women aged 18 - 35 years
- Body mass index < 30.0 kg/m2
- Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO)
- Resistance exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6 mo
- Refrain from taking any nonsteroidal anti-inflammatory drugs (e.g., aspirin, Advil®, Aleve®, Naprosyn®), or any other aspirin-containing product for 10 days before starting and at least 5 days after completing the study
- Willing to refrain from alcohol, smoking any nicotine product (includes e-cigarettes); vaping, chewing tobacco, caffeine, and dietary supplement use throughout the entire study period
- Supervisor approval for federal civilian employees and non-HRV active duty military personnel working within the US Army Natick Soldier Systems Center
Exclusion Criteria:
- Musculoskeletal injuries that compromise exercise capability as determined by the USARIEM Office of Medical Support and Oversight (OMSO)
- Metabolic or cardiovascular abnormalities, gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.)
- Abnormal PT/PTT test or problems with blood clotting
- History of complications with lidocaine
- Present condition of alcoholism, anabolic steroids, or other substance abuse issues
- Blood donation within 8-wk of beginning the study
- Pregnancy (self-report or results of urine pregnancy test before body composition testing)
- Unwillingness or inability to consume study diets or foods provided
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Standard EAA Dose
EAA dose provided at 0.10 g/kg body mass
|
EAA provided relative to body mass at a standard dose (0.10 g/kg) during energy deprivation
|
Experimental: High EAA Dose
EAA dose provided at 0.30 g/kg body mass
|
EAA provided relative to body mass at a high dose (0.30 g/kg) during energy deprivation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial, Resting Muscle Protein Synthesis Rates
Time Frame: 3 hour measure of muscle protein synthesis
|
Assessed using stable isotope infusions of phenylalanine.
|
3 hour measure of muscle protein synthesis
|
Postprandial, Post-exercise Muscle Protein Synthesis Rates
Time Frame: 3 hour measure of muscle protein synthesis
|
Assess using stable isotope infusions of phenylalanine.
|
3 hour measure of muscle protein synthesis
|
How Well Participants Suppress the Degradation of Body Proteins While Stimulating the Growth of New Proteins After Ingesting Varying Doses of EAA at Rest and After Exercise. Net Whole-body Protein Balance
Time Frame: 3 hour measure of whole-body protein balance
|
Assessed using stable isotope infusions of tyrosine.
Net Whole-body Protein Balance is defined as whole-body protein synthesis - whole-body protein breakdown)
|
3 hour measure of whole-body protein balance
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stefan M Pasiakos, PhD, Military Nutrition Division, USARIEM
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2018
Primary Completion (Actual)
March 20, 2019
Study Completion (Actual)
March 20, 2019
Study Registration Dates
First Submitted
October 31, 2017
First Submitted That Met QC Criteria
December 8, 2017
First Posted (Actual)
December 14, 2017
Study Record Updates
Last Update Posted (Actual)
November 20, 2020
Last Update Submitted That Met QC Criteria
October 28, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 17-32HC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Protein Synthesis
-
McMaster UniversityCompleted
-
Maastricht University Medical CenterWithdrawn
-
Maastricht University Medical CenterCompletedMuscle Protein SynthesisNetherlands
-
University of ExeterQuornCompletedMuscle Protein SynthesisUnited Kingdom
-
McMaster UniversityCompletedMuscle Protein SynthesisCanada
-
University of Illinois at Urbana-ChampaignCompletedMuscle Protein Synthesis | Protein MetabolismUnited States
-
University of Illinois at Urbana-ChampaignRecruiting
-
Maastricht University Medical CenterDSM Food SpecialtiesRecruiting
-
University of ExeterP.volve LLCCompletedMuscle Protein SynthesisUnited Kingdom
-
Maastricht University Medical CenterCompletedMuscle Protein SynthesisNetherlands
Clinical Trials on Standard EAA
-
United States Army Research Institute of Environmental...University of Arkansas; Eastern Michigan UniversityActive, not recruitingEnergy DeficitUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes Mellitus | Diabetic Neuropathy, Painful
-
Texas A&M UniversityUniversity of ArkansasUnknownNon-small Cell Lung CancerUnited States
-
The Swedish School of Sport and Health SciencesRecruitingObesity | Sarcopenia | Aging | Sarcopenic ObesitySweden
-
United States Army Research Institute of Environmental...University of Arkansas; Norwegian Defense Research EstablishmentCompletedWeight Loss | Military Operational Stress Reaction | Malnutrition (Calorie) | Muscle WastingNorway
-
University of NottinghamUnknownOld Age (Focus; Not a Recognized Condition)United Kingdom
-
Istituto Auxologico ItalianoRecruitingWeight Loss | Obesity MorbidItaly
-
Istituto Auxologico ItalianoCompleted
-
University of ArkansasWithdrawn
-
University of Colorado, DenverCompletedObesity | Polycystic Ovarian Syndrome | Hepatic SteatosisUnited States